Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane

Intra-amniotic Subclinical Infection. Clinical Trial

Official title: Procalcitonin Has a Role to Play in Prediction of Intra-amniotic Subclinical Infection.

Status Enrolling by invitation

Clinical Trial Summary

It is hypothesized that the procalcitonin has a role to play in prediction of intra-amniotic subclinical infection.

Clinical Trial Description

Study population

• This study will be conducted at the department of Obstetrics and Gynecology recruiting pregnant women selected from the attendees of antenatal clinic, emergency department and from inpatient wards of Ain Shams University Maternity Hospital from Mars2014.

• This study will include 100 pregnant women these cases will be divided into 2 groups:

• Group 1: Healthy preterm Group: will include 50 pregnant females all at 24-34 weeks of gestational age .

• Group 2: Preterm premature rupture of membrane Group: will include 50 pregnant females all at 24-34 weeks of gestational age ;

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Asymptomatic Infections
• Communicable Diseases
• Fetal Membranes, Premature Rupture
• Infection
• Intra-amniotic Subclinical Infection.

• NCT number: NCT02104791
• Study type: Observational
• Source: Ain Shams Maternity Hospital
• Status: Enrolling by invitation
• Phase: N/A
• Start date: May 2014